Jefferies initiates buy on Krystal Biotech with a $245 price target, citing Vyjuvek's strong growth potential and proprietary ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...
Jefferies analyst Roger Song initiated coverage of Krystal Biotech (KRYS) with a Buy rating and $245 price target Krystal is a commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback